BioengineeringbioRxivPreprint
DNA-scaffolded biomaterials enable modular and tunable control of cell-based cancer immunotherapies
Xiao Huang, Jasper Z. Williams, Ryan Chang…·Tejal A. Desai
The paper develops a biomaterial platform to control immune cell activity by modulating protein ratios on biodegradable particles, enhancing cancer immunotherapy efficacy and safety.
DOI 10.1101/587105